Microglial Ca 2+-activated K + channels are possible molecular targets for the analgesic effects of S-ketamine on neuropathic pain

Journal of Neuroscience

Volumn 31, Issue 48, 2011, Pages 17370-17382

  Hayashi, Yoshinori ^a   Kawaji, Kodai ^a   Sun, Li ^a   Zhang, Xinwen ^a   Koyano, Kiyoshi ^a   Yokoyama, Takeshi ^b   Kohsaka, Shinichi ^c   Inoue, Kazuhide ^a,d   Nakanishi, Hiroshi ^a,d  

^a KYUSHU UNIVERSITY   (Japan)

^b Faculty of Dental Science   (Japan)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,3-DIHYDRO-1-[2-HYDROXY- 5-(TRIFLUOROMETHYL)PHENYL]-5-(TRIFLUOROMETHYL)-2H-BENZIMIDAZOL-2-ONE; ADENOSINE TRIPHOSPHATE; BRAIN DERIVED NEUROTROPHIC FACTOR; CHARYBDOTOXIN; ESKETAMINE; INTERLEUKIN 1BETA; KETAMINE; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; LIPOPOLYSACCHARIDE; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PURINERGIC P2X4 RECEPTOR; R-KETAMINE; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOUSE; NERVE CELL STIMULATION; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; ROTAROD TEST;

ANALGESIA; ANALGESICS; ANIMALS; CELLS, CULTURED; HYPERALGESIA; KETAMINE; MALE; MICE; MICE, TRANSGENIC; MICROGLIA; NEURALGIA; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; SPINAL NERVES;

EID: 82555200944     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4152-11.2011     Document Type: Article

References (65)

1. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, Forrest MJ (2003) Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A 100:7947-7952.
2. Andrei C, Margiocco P, Poggi A, Lotti LV, Torrisi MR, Rubartelli A (2004) Phospholipases C and A2 control lysosome-mediated IL-1β secretion: implications for inflammatory processes. Proc Natl Acad Sci U S A 101:9745-9750.
3. Borbouse L, Dick GM, Asano S, Bender SB, Dincer UD, Payne GA, Neeb ZP, Bratz IN, Sturek M, Tune JD (2009) Impaired function of coronary BKCa channels in metabolic syndrome. Am J Physiol Heart Circ Physiol 297:H1629-H1637.
4. + currents in microglia from human hippocampi. Eur J Neurosci 18:2893-2898.
5. Chang Y, Lee JJ, Hsieh CY, Hsiao G, Chou DS, Sheu JR (2009) Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation. Mediators Inflamm 2009:705379.
6. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63.
7. Chen SR, Cai YQ, Pan HL (2009) Plasticity and emerging role ofBKCa channels in nociceptive control in neuropathic pain. J Neurochem 110:352-362.
8. Chen TL, Chang CC, Lin YL, Ueng YF, Chen RM (2009) Signal-transducing mechanisms of ketamine-caused inhibition of interleukin-1β gene expression in lipopolysaccharide-stimulated murine macrophage-like Raw 264.7 cells. Toxicol Appl Pharmacol 240:15-25.
9. Chen X, Shu S, Bayliss DA (2009) HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine. J Neurosci 29:600-609.
10. Clark AK, Staniland AA, Marchand F, Kaan TK, McMahon SB, Malcangio M (2010) P2X7-dependent release of interleukin-1β and nociception in the spinal cord following lipopolysaccharide. J Neurosci 30:573-582.
11. Coderre TJ, Kumar N, Lefebvre CD, Yu JS (2005) Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 94:1131-1139.
12. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y (2005) BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438:1017-1021.
13. Daulhac L, Maffre V, Mallet C, Etienne M, Privat AM, Kowalski-Chauvel A, Seva C, Fialip J, Eschalier A (2011) Phosphorylation of spinalN-methyl- D-aspartate receptor NR1 subunits by extracellular signal-regulated kinase in the spinal dorsal horn neurons and microglia contributes to diabetes-induced painful neuropathy. Eur J Pain 15:169e1-169e12.
14. 2+. Am J Physiol 267:C1452-C1458.
15. 2+-activated potassium (BK) channels in GH3 cells. Brain Res 638:61-68.
16. Eichenberger U, Neff F, Sveticic G, Björgo S, Petersen-Felix S, Arendt-Nielsen L, Curatolo M (2008) Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth Analg 106:1265-1273, table of contents.
17. Fujita R, Ma Y, Ueda H (2008) Lysiphosphatidic acid-induced membrane ruffling and brain-derived neurotrophic factor gene expression are mediated by ATP release in primary microglia. J Neurochem 107:152-160.
18. 2+-activated big-conductance K channels (BK) via reactive oxygen species in cultured rat aorta smooth muscle cells. Mol Cell Biochem 338:59-68.
19. Grande LA, O'Donnell BR, Fitzgibbon DR, Terman GW (2008) Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient. Anesth Analg 107:1380-1383.
20. Hayashi Y, Ishibashi H, Hashimoto K, Nakanishi H (2006a) Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors. Glia 53:660-668.
21. Hayashi Y, Tomimatsu Y, Suzuki H, Yamada J, Wu Z, Yao H, Kagamiishi Y, Tateishi N, Sawada M, Nakanishi H (2006b) The intra-arterial injection of microglia protects hippocampal CA1 neurons against global ischemiainduced functional deficits in rats. Neuroscience 142:87-96.
22. Hayashi Y, Yoshida M, Yamato M, Ide T, Wu Z, Ochi-Shindou M, Kanki T, Kang D, Sunagawa K, Tsutsui H, Nakanishi H (2008) Reverse of agedependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor A in mice. J Neurosci 28:8624-8634.
23. Hirasawa T, Ohsawa K, Imai Y, Ondo Y, Akazawa C, Uchino S, Kohsaka S (2005) Visualization of microglia in living tissues using Iba1-EGFP transgenic mice. J Neurosci Res 81:357-362.
24. Huge V, Lauchart M, Magerl W, Schelling G, Beyer A, Thieme D, Azad SC (2010) Effects of low-dose intranasal S-ketamine in patients with neuropathic pain. Eur J Pain 14:387-394.
25. Hustveit O, Maurset A, Oye I (1995) Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol Toxicol 77:355-359.
26. Inoue M, Rashid MH, Fujita R, Contos JJ, Chun J, Ueda H (2004) Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 10:712-718.
27. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36:57-68.
28. + channel KCNN4/KCa3.1 contributes to microglial activation and nitric oxide-dependent neurodegeneration. J Neurosci 27:234-244.
29. Klepstad P, Maurset A, Moberg ER, Oye I (1990) Evidence of a role for NMDA receptors in pain perception. Eur J Pharmacol 187:513-518.
30. + conductances in the generation of inferior olive rhythmicity in vivo. J Neurosci 17:2825-2838.
31. 2+-activated BK channel mRNA and its splice variants in the rat cochlea. J Comp Neurol 455:198-209.
32. Ma L, Uchida H, Nagai J, Inoue M, Aoki J, Ueda H (2010a) Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotoxin in nerve injury-induced neuropathic pain. J Pharmacol Exp Ther 333:540-546.
33. Ma L, Nagai J, Ueda H (2010b) Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain. J Neurochem 115:643-653.
34. Marietta MP, WAY WL, Castagnoli N Jr, Trevor AJ (1977) On the pharmacology of the ketamine enantiomorphs in the rat. J Pharmacol Exp Ther 202:157-165.
35. Mathisen LC, Skjelbred P, Skoglund LA, Oye I (1995) Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 61:215-220.
36. Möller T, Contos JJ, Musante DB, Chun J, Ransom BR (2001) Expression and function of lysophosphatidic acid receptors in cultured rodent microglial cells. J Biol Chem 276:25946-25952.
37. Murugan M, Sivakumar V, Lu J, Ling EA, Kaur C (2011) Expression of N-methyl-D-aspartate receptor subunits in amoeboid microglia mediates production of nitric oxide via NF-kB signaling pathway and oligodendrocyte cell death in hypoxic postnatal rats. Glia 59:521-539.
38. Nakagawa T, Wakamatsu K, Zhang N, Maeda S, Minami M, Satoh M, Kaneko S (2007) Intrathecal administration of ATP produces long-lasting allodynia in rats: differential mechanism in the phase of the induction and maintenance. Neuroscience 147:445-455.
39. Nakamichi K, Saiki M, Kitani H, Kuboyama Y, Morimoto K, Takayama-Ito M, Kurane I (2006) Suppressive effect of simvastatin on interferon-β- induced expression of CC chemokine ligand 5 in microglia. Neurosci Lett 407:205-210.
40. Noda M, Nakanishi H, Nabekura J, Akaike N (2000) AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 20:251-258.
41. Parsons CG, Gruner R, Rozental J, Millar J, Lodge D (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32:1337-1350.
42. Paton JF, Li YW, Schwaber JS (2001) Response properties of baroreceptive NTS neurons. Ann N Y Acad Sci 940:157-168.
43. Raghavendra V, Tanga F, DeLeo JA (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306:624-630.
44. Raouf R, Chabot-Dore ́ AJ, Ase AR, Blais D, Séguéla P (2007) Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPSinduced activation. Neuropharmacology 53:496-504.
45. Rigaud M, Gemes G, Barabas ME, Chernoff DI, Abram SE, Stucky CL, Hogan QH (2008) Species and strain differences in rodent sciatic nerve anatomy: implications for studies of neuropathic pain. Pain 136:188-201.
46. Ryder S, Way WL, Trevor AJ (1978) Comparative pharmacology of the optical isomers of ketamine in mice. Eur J Pharmacol 49:15-23.
47. Salt TE (1986) Mediation of thalamic sensory input by both NMDA receptors and non-NMDA receptors. Nature 322:263-265.
48. Schilling T, Eder C (2007) Ion channel expression in resting and activated microglia of hippocampal slices from juvenile mice. Brain Res 1186:21-28.
49. + channels for lysophosphatidic acid-induced microglial migration. Eur J Neurosci 19:1469-1474.
50. Schnoebel R, Wolff M, Peters SC, Bräu ME, Scholz A, Hempelmann G, Olschewski H, Olschewski A (2005) Ketamine impairs excitability in the superficial spinal dorsal horn neurones by blocking sodium and voltagegated potassium currents. Br J Pharmacol 146:826-833.
51. Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10:1361-1368.
52. Stock C, Schilling T, Schwab A, Eder C (2006) Lysophoshatidylcholine stimulates IL-1β release from microglia via a P2X7 receptor-independent mechanism. J Immunol 177:8560-8568.
53. Suter MR, Berta T, Gao YJ, Decosterd I, Ji RR (2009) Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury. Mol Pain 5:53.
54. 2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line. Biochim Biophys Acta 1726:177-186.
55. Tikka TM, Koistinaho JE (2001) Minocycline provides neuroprotection againstN-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166:7527-7533.
56. Trang T, Beggs S, Wan X, Salter MW (2009) P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci 29:3518-3528.
57. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424:778-783.
58. Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K (2004) Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45:89-95.
59. Tsuda M, Inoue K, Salter MW (2005) Neuropathic pain and spinal microglia: a big program from molecules in "small" glia. Trends Neurosci 28:101-107.
60. Tsuda M, Masuda T, Kitano J, Shimoyama H, Tozaki-Saitoh H, Inoue K (2009) IFN-γ receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc Natl Acad Sci U S A 106:8032-8037.
61. Ulmann L, Hatcher JP, Hughes JP, Chaumont S, Green PJ, Conquet F, Buell GN, Reeve AJ, Chessell IP, Rassendren F (2008) Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci 28:11263-11268.
62. Watkins LR, Milligan ED, Maier SF (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24:450-455.
63. Yokoyama R, Matsumoto S, Nomura S, Higaki T, Yokoyama T, Kiyooka S-I (2009a) Enantioselective construction of nitrogen-substituted quaternary carbon centers adjacent to the carbonyl group in the cyclohexane ring: first asymmetric synthesis of anesthetic S-ketamine with high selectivity. Tetrahedron 65:5181-5191.
64. Yokoyama T, Yokoyama R, Nomura S, Matsumoto S, Fujiyama R, Kiyooka S-I (2009b) Synthesis of S-ketamine via [1,3]-chirality transfer of a stereocenter created by enantioselective aldol reaction. Bull Chem Soc Jpn 82:1528-1532.
65. Zhang XF, Gopalakrishnan M, Shieh CC (2003) Modulation of action potential firing by iberiotoxin and NS1619 in rat dorsal root ganglion neurons. Neuroscience 122:1003-1011.